Benzinga | Sep 23, 2021 06:25AM EDT

Daiwa Capital Downgrades Amgen to Neutral, Announces $220 Price Target

Daiwa Capital analyst Narumi Nakagiri downgrades Amgen (NASDAQ:AMGN) from Outperform to Neutral and announces $220 price target.